998 studies found for:    "Bacterial Infections" | United States
Show Display Options
Rank Status Study
1 Recruiting Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections
Condition: Gram Positive Bacterial Infections
Intervention: Drug: Oritavancin
2 Completed A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children
Conditions: Bacterial Infections;   Pneumonia, Pneumocystis Carinii;   HIV Infections
Interventions: Drug: Azithromycin;   Drug: Atovaquone;   Drug: Sulfamethoxazole-Trimethoprim
3 Recruiting Dose-finding, Pharmacokinetics, Safety, and Tolerability of Meropenem-Vaborbactam in Pediatric Subjects With Serious Bacterial Infections
Condition: Bacterial Infections
Intervention: Drug: Carbavance
4 Completed Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
Condition: Gram Positive Bacterial Infection
Intervention: Drug: Daptomycin
5 Completed Early-Onset Sepsis Surveillance Study
Conditions: Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature;   Sepsis;   Gram-Negative Bacterial Infections;   Gram-Positive Bacterial Infections
Intervention:
6 Recruiting Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Condition: Bacterial Infection
Intervention: Drug: solithromycin
7 Completed Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents
Condition: Bacterial Infections
Intervention: Drug: Solithromycin
8 Completed A Single Dose Study To Investigate The Pharmacokinetics and Safety Of Dalbavancin In Hospitalized Children Aged 3 Months to 11 Years.
Condition: Bacterial Infections.
Intervention: Drug: Dalbavancin
9 Completed Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections
Condition: Bacterial Infections
Intervention: Drug: Dalbavancin
10 Completed
Has Results
Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections
Condition: Bacterial Infection
Interventions: Drug: ceftaroline;   Drug: linezolid;   Drug: Aztreonam
11 Recruiting Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant
Conditions: Bacterial Infection;   Benign Neoplasm;   Malignant Neoplasm;   Methicillin-Resistant Staphylococcus Aureus Infection;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Untreated Childhood Myeloid Neoplasm
Interventions: Drug: Chlorhexidine Gluconate;   Procedure: Wound Care Management;   Other: Questionnaire Administration;   Other: Laboratory Biomarker Analysis
12 Completed
Has Results
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
Condition: Bacterial Infections
Interventions: Drug: ceftaroline;   Drug: vancomycin plus aztreonam;   Drug: Placebo
13 Completed
Has Results
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
Condition: Bacterial Infections
Interventions: Drug: IV Vancomycin plus IV Aztreonam;   Drug: Ceftaroline
14 Terminated Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICU
Condition: Bacterial Infection
Interventions: Drug: Meropenem;   Drug: Standard antibiotic therapy
15 Completed Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Conditions: Skin and Subcutaneous Tissue Bacterial Infections;   Skin Structures and Soft Tissue Infections
Interventions: Drug: delafloxacin;   Drug: vancomycin;   Drug: aztreonam
16 Completed Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Condition: Skin and Subcutaneous Tissue Bacterial Infections
Interventions: Drug: Delafloxacin;   Drug: Vancomycin;   Drug: Aztreonam;   Drug: Placebo
17 Completed A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci
Conditions: Skin and Subcutaneous Tissue Bacterial Infections;   Wound Infection;   Cutaneous Abscess;   Burn Infection;   Cellulitis
Intervention: Drug: AFN-12520000
18 Recruiting A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013)
Condition: Gram-Positive Bacterial Infections
Interventions: Drug: Tedizolid Phosphate (IV);   Drug: Tedizolid Phosphate (oral suspension)
19 Not yet recruiting Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
Conditions: Methicillin-Resistant Staphylococcus Aureus;   Bacterial Infections;   Staphylococcal Skin Infections
Interventions: Drug: Dalbavancin single dose;   Drug: Dalbavancin two dose;   Drug: Comparator
20 Completed Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile
Conditions: Bacterial Infections;   Obesity
Intervention: Drug: Clindamycin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years